Background: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation. Aim: To quantify serum levels of fibrosis regulators in CHF. Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n=9; II, n=34; III n=23), and in 14 controls. Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1. Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF. © 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.
Eleuteri, E., Di Stefano, A., Vallese, D., Gnemmi, I., Pitruzzella, A., Tarro Genta, F., et al. (2014). Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity. BIOMARKERS, 19(3) [DOI: 10.3109/1354750X.2014.896946].
Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity.
PITRUZZELLA, Alessandro;CAPPELLO, Francesco;
2014-01-01
Abstract
Background: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation. Aim: To quantify serum levels of fibrosis regulators in CHF. Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n=9; II, n=34; III n=23), and in 14 controls. Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1. Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF. © 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.| File | Dimensione | Formato | |
|---|---|---|---|
|
Eleuteri et al., BIOM 2014.pdf
accesso aperto
Dimensione
444.07 kB
Formato
Adobe PDF
|
444.07 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


